Testing a new treatment for receding gums
ISRCTN | ISRCTN46963726 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN46963726 |
Secondary identifying numbers | 2400/S.M |
- Submission date
- 01/05/2021
- Registration date
- 13/05/2021
- Last edited
- 09/07/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English Summary
Background and study aims
Gingival recession (also known as receding gums) is when the gum tissue surrounding the teeth wears away or pulls back, exposing more of the tooth or its root. The aim of the study is to assess the effectiveness of an injectable blood extract with a gum graft during receding gums treatment.
Who can participate?
Healthy adults aged 19 and over who are non-smokers
What does the study involve?
Participants are randomly allocated to one of two treatment methods, one will involve applying the gum graft alone on the diseased tooth, while the other will involves applying an injectable blood extract before applying a gum graft on it. Participants are followed up to measure gum recession at 1, 3 and 6 months.
What are the possible benefits and risks of participating?
The possible benefits of participating are achieving full coverage for receding gums sites, less pain and better healing. The methods are safe and there are no expected risks.
Where is the study run from?
Damascus University (Syria)
When is the study starting and how long is it expected to run for?
May 2020 to July 2022
Who is funding the study?
Damascus University (Syria)
Who is the main contact?
Dr Wajiha Albattal
wajihaalbatal@gmail.com
Contact information
Scientific
Dummar
Damascus
00000
Syria
0000-0002-0250-8380 | |
Phone | +963 (0)930429851 |
wajihaalbatal@gmail.com |
Study information
Study design | Single-center interventional double-blinded randomized controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a participant information sheet |
Scientific title | The efficiency of injectable platelet-rich fibrin (i-PRF) in root surface biomodification during gingival recession treatment |
Study hypothesis | Injectable platelet-rich fibrin (i-PRF) with free gingival graft provides better root coverage compared to a free gingival graft alone during gingival recession treatment. |
Ethics approval(s) | Approved 31/08/2020, Scientific Research and Postgraduate Studies Council (Baramkeh, Damascus, Syria; +963 (0)1133923192; ap.srd@damascusuniversity.edu.sy), ref: 2400/S.M |
Condition | Gingival recession |
Intervention | Participants are randomised using a sealed envelope method. Two treatment methods will be compared, the first one will involve applying a free gingival graft alone on the root surface (control group), while the second will involve applying injectable platelet-rich fibrin (i-PRF) to a root surface before applying a free gingival graft (experimental group). Participants are followed up at 1, 3 and 6 months. |
Intervention type | Procedure/Surgery |
Primary outcome measure | 1. Gingival recession depth measured using a UNC-15 probe at baseline, 1, 3, 6 months 2. Gingival recession width measured using a UNC-15 probe at baseline, 1, 3, 6 months |
Secondary outcome measures | 1. Probing depth measured using a UNC-15 probe at baseline, 1, 3, 6 months 2. Clinical attachment level measured using a UNC-15 probe at baseline, 1, 3, 6 months 3. Keratinized tissue height measured using a UNC-15 probe at baseline, 1, 3, 6 months 4. Healing measured using a healing index at 1, 2 weeks and 1 month after surgery 5. Pain measured using a visual analogue scale (VAS) at 1 week after surgery 6. Bleeding measured using a visual analogue scale (VAS) at 1 week after surgery 7. Dentine hypersensitivity measured using a visual analogue scale (VAS) at baseline, 1, 3, 6 months |
Overall study start date | 30/05/2020 |
Overall study end date | 01/07/2022 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 42 sites (21 for each group) |
Participant inclusion criteria | 1. ≥19 years of age 2. Periodontally and systemically healthy 3. Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) <15% 4. Presence of deep Miller Class I/II GR defect (≥3 mm in depth) at the buccal aspect of incisors and canines |
Participant exclusion criteria | 1. Smoking 2. Contraindications for surgery 3. Presence of recession defects associated with caries, deep abrasion, restoration or pulpal pathology |
Recruitment start date | 30/03/2021 |
Recruitment end date | 31/12/2021 |
Locations
Countries of recruitment
- Syria
Study participating centre
Faculty of Dentistry
Mezzah
Damascus
00000
Syria
Sponsor information
University/education
Albaramkeh
Damascus
00000
Syria
Phone | +963 (0)1133923192 |
---|---|
info@damascusuniversity.edu.sy | |
Website | http://damasuniv.edu.sy/ |
https://ror.org/03m098d13 |
Funders
Funder type
University/education
No information available
Results and Publications
Intention to publish date | 01/07/2023 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal. Additional documents (such as study protocol, statistical analysis plan etc) will be available. |
IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Prof. Dr Tarik Kasem (prof.tarekkasem@hotmail.com). |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | 11/05/2023 | 09/07/2024 | Yes | No |
Editorial Notes
09/07/2024: Publication reference added.
13/05/2021: Trial's existence confirmed by Damascus University.